Explore peptide-based medicines and emerging research, with attention to evidence, safety, and questions to discuss with your medical provider.
Book Your Appointment
Physician-Guided Care
Explore the therapies below, then meet with a licensed Alpha Hormones® provider to review your health history and goals. Together, you’ll weigh the potential benefits, risks, and limitations to decide whether a peptide therapy is right for you.
When you’re ready, review our pricing and care options and book an appointment with our team.
Availability, regulatory status, approved uses, and supporting evidence vary by therapy. All treatment requires a medical evaluation and may include lab testing, a prescription, and ongoing follow-up.
BPC-157 is a synthetic peptide that comes from a protein in gastric juice. Researchers are studying it for possible effects on tissue repair, inflammation, and gut health. However, the FDA has not approved it, and most evidence comes from animal and laboratory studies. If you have questions about BPC-157, a physician at Alpha Hormones® can review the current evidence and risks with you during a consultation.
Bremelanotide (Vyleesi®) is an FDA-approved medicine for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It can cause nausea, flushing, and headache, so a physician should review whether it fits your health history. The FDA has not approved it for men.
Epitalon is a synthetic peptide that researchers have linked to possible effects on cellular aging. Some studies suggest it may influence telomeres and biological rhythms; however, the research is early, and the FDA has not approved it. If you have questions about Epitalon, a physician at Alpha Hormones® can review the current evidence and risks with you during a consultation.
This page gives an educational overview of GHK-Cu and research on its use in topical skincare, including evidence limits, FDA regulatory information, and safety considerations. The FDA has not approved GHK-Cu to treat any disease. In addition, this page does not recommend injectable GHK-Cu or provide treatment protocols.
Insulin is a peptide hormone that regulates blood sugar. After its discovery in the 1920s, it turned type 1 diabetes from a fatal disease into a manageable condition. Today, people with type 1 diabetes rely on it, and many people with type 2 diabetes need it too. Because needs differ, treatment requires close monitoring and individual dosing.
KPV is a three-amino-acid peptide that comes from alpha-MSH. Researchers are studying its possible anti-inflammatory effects on the gut and skin. However, most evidence comes from laboratory studies, and the FDA has not approved any KPV product. As a result, its safety and effectiveness in people remain unknown.
MOTS-c is a 16-amino-acid peptide from mitochondrial DNA that plays a role in cellular energy and metabolism. Researchers continue to study its effects on insulin sensitivity, glucose metabolism, and muscle. However, its benefits in people remain unproven, and researchers don’t yet know its long-term safety.
Retatrutide is an investigational peptide that acts on three receptors: GLP-1, GIP, and glucagon. Researchers are testing it in clinical trials for obesity and metabolic health, and early results show substantial weight loss. However, the FDA has not approved it, so it is available only through clinical trials.
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar. The FDA has approved it as Ozempic® for type 2 diabetes and as Wegovy® for chronic weight management in eligible patients. At Alpha Hormones® in Pasadena, a physician pairs it with nutrition and lifestyle support as part of an individualized plan.
Semax is a synthetic peptide that the FDA has not approved in the United States. Researchers have studied it for possible neurologic and cognitive effects; however, the research is limited and the results vary. In addition, no standard dose or long-term safety profile exists. If you have serious neurologic symptoms, seek emergency care right away.
Sermorelin is a synthetic peptide that prompts the pituitary gland to release more of the body’s own growth hormone. The original FDA-approved brand is no longer on the market, so sermorelin now comes from compounding pharmacies, and the FDA has not approved compounded versions. As a result, treatment requires a physician evaluation, lab testing, and ongoing monitoring.
Egrifta (tesamorelin) is an FDA-approved prescription medicine that reduces excess abdominal fat in adults with HIV-associated lipodystrophy. This page explains its approved use, limitations, safety monitoring, and insurance considerations. However, Egrifta is not a general weight-loss medicine, and coverage and eligibility depend on individual review.
TB-500 is a synthetic peptide that mimics part of thymosin beta-4, a natural protein involved in cell repair. Researchers are studying it for tissue repair and inflammation. However, the FDA has not approved it for any use in people. If you have questions about TB-500, a physician at Alpha Hormones® can review the current evidence and risks with you during a consultation.
Tirzepatide activates two hormone receptors, GLP-1 and GIP, that help regulate appetite and blood sugar. The FDA has approved it as Mounjaro® for type 2 diabetes and as Zepbound® for chronic weight management in eligible adults. At Alpha Hormones®, a physician decides whether it fits your individualized treatment plan.
